Kenyan specialists on semaglutide's heart and kidney benefits at Ozempic's local launch
Doctors at the Kenya launch of Ozempic and Wegovy cited SELECT and FLOW trial results, while warning that long-term liver evidence is still unsettled.
Recap by typeshit. Full story at K24 Digital.